New drug duo tested in fight against advanced vulvar cancer

NCT ID NCT07290894

Recruiting now Disease control Sponsor: National Cancer Institute, Naples Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a combination of two existing drugs, pembrolizumab and lenvatinib, can help control advanced vulvar cancer. It will enroll 80 women whose cancer cannot be removed by surgery, has come back, or has spread. The main goals are to see if the treatment shrinks tumors and to monitor its safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VULVA CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nation Cancer Institute of Naples, Division of Medical Oncology - Uro-Gynecology Department, Naples
RECRUITING

Naples, 80131, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VULVA CANCER